Inventor profile of:

Thomas F. Tedder

City:

Durham, North Carolina

Country:

United States

Published Applications:

30

Last publication date:

2024-01-25

Top Assignees for applications by Thomas F. Tedder

The entities that hold a legal rights for patent applications filed by inventor Tedder Thomas F.:

Recent patent applications by Tedder Thomas F.

Thomas F. Tedder from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-25
US20240026346A1
Chemistry; metallurgy

ANTIGEN DISPLAY SYSTEM AND METHODS FOR CHARACTERIZING ANTIBODY RESPONSES

#2 | 2024-01-11
US20240011015A1
Chemistry; metallurgy

ANTIGEN DISPLAY SYSTEM AND METHODS FOR CHARACTERIZING ANTIBODY RESPONSES

#3 | 2023-09-21
US20230295562A1
Chemistry; metallurgy

REGULATORY B CELLS AND THEIR USES

#4 | 2020-09-10
US20200283727A1
Chemistry; metallurgy

METHODS OF EXPANDING AND ASSESSING B CELLS AND USING EXPANDED B CELLS TO TREAT DISEASE

#5 | 2020-07-30
US20200239872A1
Chemistry; metallurgy

ANTIGEN DISPLAY SYSTEM AND METHODS FOR CHARACTERIZING ANTIBODY RESPONSES

#6 | 2019-12-05
US20190367607A1
Chemistry; metallurgy

Antibodies and methods for depleting regulatory bio cells and use in combination with immune checkpoint inhibitors

#7 | 2019-11-21
US20190352607A1
Chemistry; metallurgy

METHODS FOR EXPANDING AND DIFFERENTIATING B CELLS FOR PRODUCING ANTIBODY

#8 | 2019-05-09
US20190136185A1
Chemistry; metallurgy

REGULATORY B CELLS AND THEIR USES

#9 | 2018-10-11
US20180291340A1
Chemistry; metallurgy

Methods of expanding and assessing B cells and using expanded B cells to treat disease

#10 | 2017-03-30
US20170088625A1
Chemistry; metallurgy

CD-20-SPECIFIC ANTIBODIES AND METHODS OF EMPLOYING SAME

#11 | 2016-12-29
US20160375059A1
Human necessities

Regulatory B cells and their uses

#12 | 2014-03-06
US20140065118A1
Chemistry; metallurgy

Methods of expanding and assessing B cells and using expanded B cells to treat disease

#13 | 2014-02-27
US20140056896A1
Chemistry; metallurgy

Anti-CD19 antibodies and uses in B cell disorders

#14 | 2013-05-30
US20130136754A1
Chemistry; metallurgy

Regulatory B cells and their uses

#15 | 2013-04-04
US20130084294A1
Human necessities

ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS

#16 | 2012-11-29
US20120301472A1
Chemistry; metallurgy

Reagents and treatment methods for autoimmune diseases

#17 | 2011-06-09
US20110135666A1
Human necessities

Regulatory B cells and their uses

#18 | 2011-05-05
US20110104150A1
Chemistry; metallurgy

Anti-CD19 antibodies and uses in B cell disorders

#19 | 2010-06-24
US20100158901A1
Chemistry; metallurgy

ANTI-CD19 ANTIBODY THERAPY FOR AUTOIMMUNE DISEASE

#20 | 2009-11-19
US20090285808A1
Chemistry; metallurgy

ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY

#21 | 2009-10-01
US20090246195A1
Human necessities

ANTI-CD19 ANTIBODY THERAPY FOR TRANSPLANTATION

#22 | 2009-05-28
US20090136516A1
Chemistry; metallurgy

CD-20 specific antibodies and methods of employing same

#23 | 2008-05-22
US20080118505A1
Chemistry; metallurgy

Reagents and treatment methods for autoimmune diseases

#24 | 2007-11-15
US20070264260A1
Chemistry; metallurgy

Treatment methods using anti-CD22 antibodies

#25 | 2006-12-14
US20060280738A1
Human necessities

Anti-CD19 antibody therapy for transplantation

#26 | 2006-11-23
US20060263357A1
Chemistry; metallurgy

Anti-CD19 antibody therapy for autoimmune disease

#27 | 2006-10-19
US20060233791A1
Chemistry; metallurgy

Anti-CD19 antibodies and uses in oncology

#28 | 2006-06-22
US20060134751A1
Chemistry; metallurgy

Identification of novel MS4A gene family members expressed by hematopoietic cells

#29 | 2006-01-26
US20060021069A1
Chemistry; metallurgy

Antibody production methods related to disruption of peripheral tolerance in B lymphocytes

#30 | 2005-07-26
US9555349
-

Antibody production methods relating to disruption of peripheral tolerance in B lympho-cytes

InventorID:

176380 ⎘